Merck & Co. Inc. closed 32.72% below its 52-week high of $134.63, which the company achieved on June 25th.
Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for ...
A new government report adds to evidence that the HPV vaccine, once called dangerous by Health and Human Services Secretary ...
As Merck & Co. hunts for an ideal spot to set up a new commercial facility, Delaware is looking to bolster its odds with a ...
Novavax is starting to look like a vaccine development company again. And 2025 stands to be a big year for the local biotech.
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...
We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...
Gene's lead asset shows high complete response rates in BCG-unresponsive NMIBC patients. Click here to read why ENGN stock is ...
Hosted on MSN19h
Drugmaker Merck To Increase Workforce Across India - DetailsDrugmaker Merck or MSD, is expected to increase its workforce across its sites in India by the end of 2025, a senior company ...
The cancellation plays into fears among scientists who worry that Robert F. Kennedy Jr. will use his position as health ...
Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Merck & Co., Inc. (NYSE: MRK) between February 3, 2022 and February 3, 2025, both dates inclusive (the "Class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results